|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/02 | |
| A61K 31/519 | |||
| A61K 31/5377 |
| (11) | Number of the document | 3200879 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15771930.3 |
| Date of filing the European patent application | 2015-09-29 | |
| (97) | Date of publication of the European application | 2017-08-09 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/072386 |
| Date | 2015-09-29 |
| (87) | Number | WO 2016/050749 |
| Date | 2016-04-07 |
| (30) | Number | Date | Country code |
| 14187331 | 2014-10-01 | EP |
| (72) |
TAUBE, Tillmann, DE
RUDOLPH, Dorothea, DE
|
| (73) |
Boehringer Ingelheim International GmbH & Co. KG,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME III |
| COMBINATION TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME III |